Health care utilization in patients with spondyloarthropathies

Por Singh, J. A., Strand, V.
Publicado em 2009

Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis

Por Strand, V, Landewe, R, van der Heijde, D
Publicado em 2002

Effectiveness and Safety of a Multicenter Extension and Retreatment Trial of Gel-200 in Patients with Knee Osteoarthritis

Por Strand, V., Baraf, H.S.B., Lavin, P.T., Lim, S., Hosokawa, H.
Publicado no Cartilage (2012)

Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years

Por van der Heijde, D, Kalden, J, Scott, D, Smolen, J, Strand, V
Publicado em 2004

OMERACT 7 psoriatic arthritis workshop: synopsis

Por Gladman, D, Strand, V, Mease, P, Antoni, C, Nash, P, Kavanaugh, A
Publicado em 2005

Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases

Por Strand, V, Crawford, B, Singh, J, Choy, E, Smolen, J S, Khanna, D
Publicado em 2009

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis

Por Scott, I C, Ibrahim, F, Lewis, C M, Scott, D L, Strand, V
Publicado no RMD Open (2016)

Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported s...

Por Chung, C P, Thompson, J L, Koch, G G, Amara, I, Strand, V, Pincus, T
Publicado em 2006

Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease Related Interstitial Lung Dis...

Por Saketkoo, LA, Mittoo, S, Frankel, S, LeSage, D, Sarver, C, Phillips, K, Strand, V, Matteson, EL
Publicado no J Rheumatol (2014)

ACR Hybrid Analysis of Certolizumab Pegol Plus Methotrexate in Patients With Active Rheumatoid Arthritis: Data From the RAPID 1 Trial

Por van Vollenhoven, R.F., Felson, D., Strand, V., Weinblatt, M.E., Luijtens, K., Keystone, E. C.
Publicado em 2011

Toward Development of a Fibromyalgia Responder Index and Disease Activity Score: OMERACT Module Update

Por Mease, PJ, Clauw, DJ, Christensen, R, Crofford, L, Gendreau, M, Martin, SA, Simon, L, Strand, V, Williams, DA, Arnold, LM
Publicado em 2011

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD st...

Por Fleischmann, R, Vencovsky, J, van Vollenhoven, R F, Borenstein, D, Box, J, Coteur, G, Goel, N, Brezinschek, H-P, Innes, A, Strand, V
Publicado em 2008

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Por Smolen, J, Landewé, R B, Mease, P, Brzezicki, J, Mason, D, Luijtens, K, van Vollenhoven, R F, Kavanaugh, A, Schiff, M, Burmester, G R, Strand, V, Vencovský, J, van der Heijde, D
Publicado em 2008